About us

Sugentech Inc. develops in-vitro diagnostic systems and products
based on BT-IT-NT convergence technology

CEO Message

“Only the appropriate diagnosis in a timely manner could lead to the impactful clinical solution and the right continuum of clinical care”

 For more than last 20 years, I have been committed to the R&D of in-vitro diagnostics with the unwavering belief that the field of "diagnosis" can provide humanity with important values beyond the development of "new drugs". In order to conquer a disease, the appropriate biomarker has to be discovered, and the disease should be properly defined with this marker. But the proper definition is not enough.

The IVD has to embrace the value of the guide to the better prescription, as well as the earlier and easier diagnosis.

True health starts with knowing my body exactly rather than just curing with medication or surgery.

Technology to monitor disease prognosis accurately,
Technology to make it easier to self-diagnose,
Diagnostic technology to facilitate personalized medicine, etc.

The entrepreneurial adventure of Sugentech is rooted in a strong commitment to serve public heath with a faithful pursuit of these value and strong scientific approach.  

We Sugentech members believe we are sure to grow as much as the value that we offer to the community and share the glowing success with each member of community.

All of our employees, including myself, will continue to present a new future in the field of in vitro diagnostics with a constant passion and responsibility to achieve the mission of 'helping people live healthier lives.’

Thank you for your support and encouragement.

CEO & President of Sugentech Inc.